Related Experiment Video
Updated: Nov 24, 2025
Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
Published on: April 28, 2023
Balloon Dilation for Obstructive Eustachian Tube Dysfunction in Children
Joonas Toivonen1,2, Kosuke Kawai1, Joshua Gurberg1
1Department of Otolaryngology and Communication Enhancement, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
Insights
Balloon dilation of the Eustachian tube (BDET) offers a safe and effective treatment for pediatric chronic Eustachian tube dysfunction (ETD). This procedure showed significant improvements in ear health and a lower failure rate compared to traditional tympanostomy tube insertions.
Area of Science:
- Otolaryngology
- Pediatric Otology
- Interventional Otology
Background:
- Chronic Eustachian tube dysfunction (ETD) significantly impacts children's quality of life.
- Persistent ETD often necessitates interventions beyond initial tympanostomy tube (TT) placement.
- Evaluating novel procedures like balloon dilation of the Eustachian tube (BDET) is crucial for pediatric otologic care.
Purpose of the Study:
- To determine the safety and efficacy of balloon dilation of the Eustachian tube (BDET) in pediatric patients with chronic ETD.
- To compare the outcomes of BDET with traditional tympanostomy tube (TT) insertion in a matched cohort.
- To assess long-term functional and structural improvements in the Eustachian tube and middle ear.
Main Methods:
- A retrospective matched cohort study was conducted at a tertiary medical center.
- Pediatric patients (<18 years) with persistent chronic ETD (>1.5 years) were included, comparing BDET with concomitant procedures to a control group with TT insertion.
- Outcomes assessed included otitis media with effusion, tympanostomy status, tympanometry, audiometry, otomicroscopy, ET mucosal inflammation, and Valsalva maneuver performance.
Main Results:
- Significant improvements in tympanic membrane health, tympanogram results (Type A), and reduced ET mucosal inflammation were observed post-BDET.
- The probability of being failure-free at 2 years was higher for BDET (87%) compared to TT insertion (56%).
- BDET demonstrated a significantly lower risk of failure (adjusted HR 0.26; P=.007) compared to TT insertion.
Conclusions:
- Balloon dilation of the Eustachian tube (BDET) is a safe and effective procedure for selected pediatric patients suffering from chronic ETD.
- BDET offers a promising alternative with superior long-term outcomes compared to conventional tympanostomy tube management.
- Further research may explore optimal patient selection criteria and refine BDET techniques for broader application.
Objective:
Determine the safety and efficacy of balloon dilation of the Eustachian tube (ET) in pediatric patients.
Study Design:
Retrospective matched cohort study.
Setting:
Tertiary medical center.
Patients:
Pediatric patients (<18 yr) with persistent (>1.5 yr) chronic Eustachian tube dysfunction (ETD) with previous tympanostomy tube (TT) insertion versus matched controls.
Interventions:
Balloon dilation of the cartilaginous ET (BDET) was performed using concomitant myringotomy with/without tube placement and adjunctive procedures if indicated versus controls (TT).
Main Outcome Measures:
Otitis media with effusion (OME)/retraction with need for additional tube, tympanogram, audiogram, otomicroscopy, ET mucosal inflammation/opening score, and Valsalva maneuver.
Results:
Forty six ETs (26 patients), ages 7 to 17 years (mean 12.5) underwent BDET. Mean follow-up was 2.3 years (standard deviation [SD], 1.1; range, 6 mo-5 yr). Significant improvements were observed for all measures. Tympanic membranes were healthy in 9% preoperatively, 38% at 6 months, 55% at 12 months, and 93% at 36 months postoperatively. Tympanograms improved to type A in 50% at 6 months, 59% at 12 months, and 85% at 36 months. Mean scores of mucosal inflammation declined from 3.2 (±0.6) preoperatively to 2.5 (±0.7) at 6 months and 1.7 (±0.6) at 36 months postoperatively. BDET had lower risk of failure versus TT insertion (adjusted hazard ratio [HR] 0.26; 95% confidence interval [CI]: 0.10, 0.70; p = 0.007). Probability of being failure free at 2 years was 87% (95% CI: 70, 94%) after BDET and 56% (95% CI: 40, 70%) after TT insertions.
Conclusions:
BDET is a safe and possibly effective procedure in selected pediatric patients with chronic ETD.
More Related Videos
06:13Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
09:07Author Spotlight: Advancing Endoscopic Ossiculoplasty – Techniques, Innovations, and Practical Guidance for Clinical Integration
Published on: January 26, 2024
